Songlin Xue, M.D., Ph.D., has been named head of Global Pharmacovigilance at Astellas Pharma, Inc. Dr. Xue will be based at Astellas’ headquarters for the Americas in Northbrook, IL, and will report to Sef Kurstjens, M.D., Ph.D., chief medical officer at Astellas.   Dr. Xue has more than 20 years of pharmaceutical industry experience, and has held increasingly senior roles with global responsibilities in drug safety and pharmacoepidemiology. Most recently, Dr. Xue served as senior vice pre...